Total 147 | Not vaccinated 106 | Vaccinated 41 | p | Risk (95% CI) | |
---|---|---|---|---|---|
Weight | |||||
< 2500 or > 4000 g | 22 (15.0) | 13 (12.3) | 9 (22.0) | 0.140 | 1.79 (0.83–3.86) |
2500–4000 g | 125 (85.0) | 93 (87.7) | 32 (78.0) | 2.19 (0.53–9.06) | |
Sex | |||||
Male | 79 (63.7) | 58 (55.7) | 20 (48.8) | 0.453 | 0.88 (0.61–1.25) |
Female | 68 (46.3) | 47 (44.3) | 21 (51.2) | 1.16 (0.80–1.67) | |
Cord arterial pH | |||||
< 7.20 | 20 (16.8) | 14 (16.1) | 6 (18.8) | 0.731 | 1.17 (0.49–2.77) |
≥ 7.20 | 99 (83.2) | 73 (83.9) | 26 (81.2) | 0.97 (0.80–1.17) | |
1-minute Apgar score | |||||
< 7 | 8 (5.4) | 8 (7.5) | 0 (0) | 0.070 | - |
≥ 7 | 139 (94.6) | 98 (92.5) | 41 (100) | 1.08 (1.02–1.14) | |
5-minute Apgar score | |||||
< 7 | 3 (2) | 3 (2.8) | 0 (0) | 0.276 | - |
≥ 7 | 144 (98) | 103 (97.2) | 41 (100) | 1.03 (1.0–1.06) | |
Neonatal destination | |||||
Maternity | 131 (89.1) | 95 (89.6) | 36 (87.8) | 0.751 | 0.98 (0.86–1.12) |
Neonatal ICU | 16 (10.9) | 11 (10.4) | 5 (12.2) | 1.18 (0.44–3.18) | |
Neonatal complications | |||||
Yes | 41 (27.9) | 23 (21.7) | 10 (24.4) | 0.726 | 1.12 (0.59–2.15) |
No | 106 (72.1) | 83 (78.3) | 31 (75.6) | 0.97 (0.79–1.18) | |
Lactation | |||||
Maternal | 124 (86.1) | 91 (88.3) | 33 (80.5) | 0.218 | 0.91 (0.77–1.08) |
Artificial | 20 (13.9) | 12 (11.7) | 8 (19.5) | 1.68 (0.74–3.80) | |
Skin-to-skin | |||||
Yes | 120 (82.2) | 83 (79) | 37 (90.2) | 0.112 | 1.14 (0.99–1.31) |
No | 26 (17.8) | 22 (21) | 4 (9.8) | 0.47 (1.17–1.27) |